Committed to high-impact actions required for eliminating TB by 2025, says JP Nadda

Addressing the World Health Organisation (WHO) Regional Health Ministers’ Meeting on Tuberculosis, the Union Minister of Health and Family Welfare also highlighted achievements of India in containing TB

Union Minister of Health and Family Welfare addresses WHO Regional Health Ministers’ Meet on TB held in Delhi on March 15
Union Minister of Health and Family Welfare addresses WHO Regional Health Ministers’ Meet on TB held in Delhi on March 15

“My government has committed itself to the high-impact actions required for eliminating TB by 2025 and will be reinforcing the implementation of our national efforts so that we succeed,” said JP Nadda, Union Minister of Health and Family Welfare at the World Health Organisation (WHO) Regional Health Ministers’ Meeting on tuberculosis (TB), held in Delhi on March 15.

The Health Minister reaffirmed India’s commitment in the global collective efforts towards combating TB and stated that India will be remembered for suggesting new breakthroughs aimed at ending TB in the eleven countries of WHO South-East Asia Region (SEAR) through renewed political and financial commitment and enhanced regional cooperation.

Also present were health ministers from WHO South East Asia Region and Western Pacific Region countries of Bangladesh, Bhutan, South Korea, Indonesia, Maldives, Nepal, Sri Lanka, Thailand, and TimorLeste.

Nadda pointed out that WHO SEAR is disproportionately affected by problem of tuberculosis. The drug resistant TB is as larger problem affecting our populations and significantly contributing to the morbidity and mortality.

“Each country in the region is having unique and diverse challenges. We, in the region can share our experiences, success stories and strategies to effectively counter the menace of tuberculosis,” Nadda added.

Highlighting the gains made by India, Nadda said the government has called for a meeting to end TB by 2025 and has accelerated action in this regard.

A high proportion, almost 92%, of TB patients with HIV has been put on antiretroviral therapy. He also added that more than 500 CBNAAT machines have been rolled out in one year, offering rapid quality diagnostics, linking at least one such machine for each district.

“These steps have led to 35% rise in the drug resistant TB case notification in 2016. New anti-TB drug Bedaquiline has been introduced under Conditional Access Programme (CAP) to improve outcomes of drug resistant TB treatment. I am happy to state that progress in TB has been significant in recent times,” Nadda said.

Appreciating WHO’s role in regional learning and innovation and promoting south to south collaboration in fighting the disease together, the Nadda urged WHO to include tuberculosis in its global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics.

Speaking at the meet, Dr Poonam Khetrapal Singh, Regional Director of WHO South-East Asia, stated that TB is the leading cause of death in the region and 15-49 years age group is most affected.

She stated that there is an urgent need to position TB as a key national health and development issue. This will also require tackling poverty and deprivation and corresponding investment in next ten years.

Also present on this occasion were distinguished delegates from WHO South-East Asia Region (SEAR) countries, representatives of NGOs and development partners and other senior officers of the Health Ministry.